Tenon Medical, Inc.
TNONWDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 1 past
Regulatory Decision - sacropelvic
Tenon received FDA 510(k) clearance for its sacropelvic product and outlined plans to launch over the next six to nine months.
FDA 510(k) clearance received
No drugs found in this phase.
Frequently asked questions
When is Tenon Medical, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Tenon Medical, Inc. (TNONW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TNONW biotech catalysts?→
Add TNONW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tenon Medical, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.